Cargando…

Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea

Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homeca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sungha, Mun, Sujeong, Park, Jeonghwan, Choi, Sunmi, Lee, Sanghun, Kim, Sungchul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683772/
https://www.ncbi.nlm.nih.gov/pubmed/31428170
http://dx.doi.org/10.1155/2019/4217057
_version_ 1783442152235204608
author Kim, Sungha
Mun, Sujeong
Park, Jeonghwan
Choi, Sunmi
Lee, Sanghun
Kim, Sungchul
author_facet Kim, Sungha
Mun, Sujeong
Park, Jeonghwan
Choi, Sunmi
Lee, Sanghun
Kim, Sungchul
author_sort Kim, Sungha
collection PubMed
description Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homecare services for mechanical ventilation in South Korea. This study comprised a face-to-face cross-sectional survey with staff members available to address any queries. Fifty-five participants were included; all had used >1 CAM treatment option for ALS symptoms. Dietary treatments were most common, followed by functional food and massages. Most participants had obtained relevant information from family members or friends. The main reason for CAM use was an expectation that symptoms will improve with CAM; most patients were unsure of the effects. CAM use was previously discontinued by the majority of patients because of unsatisfactory effects. The mean expenditure on CAM was 288,385.28 ± 685,265.14 won per month, and the mean duration of CAM use was 11.54 ± 20.09 months. The results indicate that there is a high prevalence of CAM use among ALS patients. Healthcare providers should inquire about CAM use and openly provide accurate CAM information. Further evidence of CAM efficacy is required, as is specific guidance for consulting ALS patients regarding CAM.
format Online
Article
Text
id pubmed-6683772
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66837722019-08-19 Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea Kim, Sungha Mun, Sujeong Park, Jeonghwan Choi, Sunmi Lee, Sanghun Kim, Sungchul Evid Based Complement Alternat Med Research Article Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homecare services for mechanical ventilation in South Korea. This study comprised a face-to-face cross-sectional survey with staff members available to address any queries. Fifty-five participants were included; all had used >1 CAM treatment option for ALS symptoms. Dietary treatments were most common, followed by functional food and massages. Most participants had obtained relevant information from family members or friends. The main reason for CAM use was an expectation that symptoms will improve with CAM; most patients were unsure of the effects. CAM use was previously discontinued by the majority of patients because of unsatisfactory effects. The mean expenditure on CAM was 288,385.28 ± 685,265.14 won per month, and the mean duration of CAM use was 11.54 ± 20.09 months. The results indicate that there is a high prevalence of CAM use among ALS patients. Healthcare providers should inquire about CAM use and openly provide accurate CAM information. Further evidence of CAM efficacy is required, as is specific guidance for consulting ALS patients regarding CAM. Hindawi 2019-07-25 /pmc/articles/PMC6683772/ /pubmed/31428170 http://dx.doi.org/10.1155/2019/4217057 Text en Copyright © 2019 Sungha Kim et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kim, Sungha
Mun, Sujeong
Park, Jeonghwan
Choi, Sunmi
Lee, Sanghun
Kim, Sungchul
Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title_full Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title_fullStr Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title_full_unstemmed Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title_short Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea
title_sort complementary and alternative medicine use in amyotrophic lateral sclerosis cases in south korea
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683772/
https://www.ncbi.nlm.nih.gov/pubmed/31428170
http://dx.doi.org/10.1155/2019/4217057
work_keys_str_mv AT kimsungha complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea
AT munsujeong complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea
AT parkjeonghwan complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea
AT choisunmi complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea
AT leesanghun complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea
AT kimsungchul complementaryandalternativemedicineuseinamyotrophiclateralsclerosiscasesinsouthkorea